Published in Pediatrie on January 01, 1993
Second consensus statement on the diagnosis of multiple system atrophy. Neurology (2008) 7.27
Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus. Proc Natl Acad Sci U S A (1999) 3.77
Molecular analysis of aldolase B genes in hereditary fructose intolerance. Lancet (1990) 3.28
Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations. Am J Hum Genet (2004) 2.62
Glucocorticoid receptor alpha and beta in glucocorticoid dependent asthma. Am J Respir Crit Care Med (2000) 2.36
Frequency of the DYT1 mutation in primary torsion dystonia without family history. Arch Neurol (2000) 2.17
Specific binding sites in the alcR and alcA promoters of the ethanol regulon for the CREA repressor mediating carbon catabolite repression in Aspergillus nidulans. Mol Microbiol (1993) 2.13
Dengue virus type 1 nonstructural glycoprotein NS1 is secreted from mammalian cells as a soluble hexamer in a glycosylation-dependent fashion. J Virol (1999) 2.07
Ataxia with isolated vitamin E deficiency: neurological phenotype, clinical follow-up and novel mutations in TTPA gene in Italian families. Neurol Sci (2004) 1.92
Assessing tremor severity. J Neurol Neurosurg Psychiatry (1993) 1.92
Follow-up of nine patients with Hurler syndrome after bone marrow transplantation. J Pediatr (1998) 1.91
Structural abnormalities in the cerebellum and sensorimotor circuit in writer's cramp. Neurology (2007) 1.91
A novel DCC mutation and genetic heterogeneity in congenital mirror movements. Neurology (2011) 1.88
Mitochondrial very-long-chain acyl-coenzyme A dehydrogenase deficiency: clinical characteristics and diagnostic considerations in 30 patients. Clin Chim Acta (1998) 1.81
Genotypic and phenotypic spectrum in tricho-rhino-phalangeal syndrome types I and III. Am J Hum Genet (2000) 1.80
Maternally inherited myopathy and cardiomyopathy: association with mutation in mitochondrial DNA tRNA(Leu)(UUR). Lancet (1991) 1.73
Pallidal stimulation for Parkinson's disease. Two targets? Neurology (1997) 1.69
Evaluation of the Duke criteria versus the Beth Israel criteria for the diagnosis of infective endocarditis. Clin Infect Dis (1995) 1.65
Arbitrarily primed polymerase chain reaction as a rapid method to differentiate crossed from independent Pseudomonas cepacia infections in cystic fibrosis patients. J Clin Microbiol (1993) 1.60
The mouse dystonia musculorum gene is a neural isoform of bullous pemphigoid antigen 1. Nat Genet (1995) 1.60
Clustering of mutations responsible for branchio-oto-renal (BOR) syndrome in the eyes absent homologous region (eyaHR) of EYA1. Hum Mol Genet (1997) 1.59
Structure of the Sec7 domain of the Arf exchange factor ARNO. Nature (1998) 1.57
Crystal structure of enoyl-coenzyme A (CoA) hydratase at 2.5 angstroms resolution: a spiral fold defines the CoA-binding pocket. EMBO J (1996) 1.55
Expression of the Sonic hedgehog (SHH ) gene during early human development and phenotypic expression of new mutations causing holoprosencephaly. Hum Mol Genet (1999) 1.53
TENS is harmful in primary writing tremor. Clin Neurophysiol (2010) 1.52
EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease. Eur J Neurol (2013) 1.52
Homogentisic acid determined in biological fluids by HPLC. Clin Chem (1989) 1.50
Outcome of 27 patients with Hurler's syndrome transplanted from either related or unrelated haematopoietic stem cell sources. Bone Marrow Transplant (2003) 1.50
Cell cycle-dependent recruitment of HDAC-1 correlates with deacetylation of histone H4 on an Rb-E2F target promoter. EMBO Rep (2001) 1.47
Update on transcobalamin deficiency: clinical presentation, treatment and outcome. J Inherit Metab Dis (2013) 1.47
doublecortin is the major gene causing X-linked subcortical laminar heterotopia (SCLH). Hum Mol Genet (1998) 1.44
[112 cases of sporadic and genetically determined pheochromocytoma: a comparative pathologic study]. Ann Pathol (1999) 1.44
Gene transfer to human rheumatoid synovial tissue engrafted in SCID mice. J Rheumatol (1997) 1.43
GM2-gangliosidosis B1 variant: analysis of beta-hexosaminidase alpha gene abnormalities in seven patients. Am J Hum Genet (1990) 1.43
The putative glucose 6-phosphate translocase gene is mutated in essentially all cases of glycogen storage disease type I non-a. Eur J Hum Genet (1999) 1.42
[Feeding of infants based on age. Practice guidelines]. Arch Pediatr (2003) 1.40
[Home chemotherapy for lung cancer: a five year retrospective study]. Rev Mal Respir (2003) 1.40
[Spontaneous colonic perforations revealing Ehlers-Danlos syndrome type IV]. Arch Pediatr (1995) 1.40
Cerebral venous thrombosis in Behçet's disease: clinical study and long-term follow-up of 25 cases. Neurology (1992) 1.40
Clinical characteristics and topography of lesions in movement disorders due to thalamic lesions. Neurology (2001) 1.39
[Severe viper venom poisoning. Apropos of 7 pediatric cases]. Arch Fr Pediatr (1991) 1.39
Interactions between 6-mercaptopurine therapy and thiopurine-methyl-transferase (TPMT) activity. Eur J Clin Pharmacol (1994) 1.39
Absence of dystrophin and utrophin in a boy with severe muscular dystrophy. N Engl J Med (1994) 1.39
Environmental regulation of Bacillus subtilis sigma(D)-dependent gene expression. J Bacteriol (2000) 1.39
Molecular analysis of pericentrin gene (PCNT) in a series of 24 Seckel/microcephalic osteodysplastic primordial dwarfism type II (MOPD II) families. J Med Genet (2009) 1.38
Mutations in a polycistronic nuclear gene associated with molybdenum cofactor deficiency. Nat Genet (1998) 1.38
L-2-hydroxyglutaric aciduria and brain malignant tumors: a predisposing condition? Neurology (2004) 1.36
Levodopa-responsive dystonia. GTP cyclohydrolase I or parkin mutations? Brain (2000) 1.36
Structural basis for human monoglyceride lipase inhibition. J Mol Biol (2009) 1.32
Adult neuronal ceroid lipofuscinosis with palmitoyl-protein thioesterase deficiency: first adult-onset patients of a childhood disease. Ann Neurol (2001) 1.32
Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology. Mov Disord (1994) 1.32
Propriospinal myoclonus revisited: Clinical, neurophysiologic, and neuroradiologic findings. Neurology (2009) 1.30
Methods for a prompt and reliable laboratory diagnosis of Pompe disease: report from an international consensus meeting. Mol Genet Metab (2007) 1.29
A gene on chromosome 11q23 coding for a putative glucose- 6-phosphate translocase is mutated in glycogen-storage disease types Ib and Ic. Am J Hum Genet (1998) 1.28
Human brain mapping in dystonia reveals both endophenotypic traits and adaptive reorganization. Ann Neurol (2001) 1.28
Clinical, biochemical and neuroradiological findings in L-2-hydroxyglutaric aciduria. Neurol Sci (2000) 1.24
Very long chain acyl-CoA dehydrogenase deficiency: identification of a new inborn error of mitochondrial fatty acid oxidation in fibroblasts. Biochim Biophys Acta (1993) 1.24
Dilative arteriopathy and basilar artery dolichoectasia complicating late-onset Pompe disease. Neurology (2008) 1.22
Myoclonus-dystonia: clinical and electrophysiologic pattern related to SGCE mutations. Neurology (2008) 1.21
Nuclear DNA origin of cytochrome c oxidase deficiency in Leigh's syndrome: genetic evidence based on patient's-derived rho degrees transformants. Hum Mol Genet (1995) 1.20
Linkage of benign familial infantile convulsions to chromosome 16p12-q12 suggests allelism to the infantile convulsions and choreoathetosis syndrome. Am J Hum Genet (2001) 1.19
Treatment of DYT1-generalised dystonia by stimulation of the internal globus pallidus. Lancet (2000) 1.19
Cloning and characterization of human very-long-chain acyl-CoA dehydrogenase cDNA, chromosomal assignment of the gene and identification in four patients of nine different mutations within the VLCAD gene. Hum Mol Genet (1996) 1.17
Identification of new mutations in the ETHE1 gene in a cohort of 14 patients presenting with ethylmalonic encephalopathy. J Med Genet (2008) 1.16
Respiratory chain and mitochondrial DNA in muscle and brain in Parkinson's disease patients. Neurology (1993) 1.16
Human molybdopterin synthase gene: genomic structure and mutations in molybdenum cofactor deficiency type B. Am J Hum Genet (1999) 1.15
In utero transplantation of stem cells in humans: immunological aspects and clinical follow-up of patients. Bone Marrow Transplant (1992) 1.14
N-terminal arm exchange is observed in the 2.15 A crystal structure of oxidized nitrite reductase from Pseudomonas aeruginosa. Structure (1997) 1.14
Linkage mapping of benign familial infantile convulsions (BFIC) to chromosome 19q. Hum Mol Genet (1997) 1.13
Variant of GM2-gangliosidosis with hexosaminidase A having a severely changed substrate specificity. EMBO J (1983) 1.13
Fumarase deficiency is an autosomal recessive encephalopathy affecting both the mitochondrial and the cytosolic enzymes. Neurology (1990) 1.11
Disorganized somatotopy in the putamen of patients with focal hand dystonia. Neurology (2005) 1.10
Gaucher disease: the origins of the Ashkenazi Jewish N370S and 84GG acid beta-glucosidase mutations. Am J Hum Genet (2000) 1.09
Regulation of alcR, the positive regulatory gene of the ethanol utilization regulon of Aspergillus nidulans. Mol Microbiol (1987) 1.09
PRRT2 mutations and paroxysmal disorders. Eur J Neurol (2013) 1.08
[Organization and computerization of a cell bank (proceedings)]. Ann Biol Clin (Paris) (1978) 1.07
[Hydroxy-methyl-glutaryl-coenzyme A lyase deficiency manifesting as Reye's syndrome in a 3-year-old girl]. Pediatrie (1993) 1.07
Encephalopathy with calcifications of the basal ganglia in children. A reappraisal of Fahr's syndrome with respect to 14 new cases. Neuropediatrics (1989) 1.07
Identification of the promoter region involved in the autoregulation of the transcriptional activator ALCR in Aspergillus nidulans. Mol Cell Biol (1992) 1.06
[Biological diagnosis of hereditary metabolic diseases. From selective screening to the mutant-cell bank]. Ann Biol Clin (Paris) (1988) 1.06
Dystonin-deficient mice exhibit an intrinsic muscle weakness and an instability of skeletal muscle cytoarchitecture. Dev Biol (1999) 1.05
Familial cortical myoclonic tremor with epilepsy: the third locus (FCMTE3) maps to 5p. Neurology (2010) 1.05
International Federation of Clinical Chemistry, Scientific Division Committee on Enzymes: approved recommendation on IFCC methods for the measurement of catalytic concentration of enzymes. Part 7. IFCC method for creatine kinase (ATP: creatine N-phosphotransferase, EC 2.7.3.2). Eur J Clin Chem Clin Biochem (1991) 1.05
Segregation of the G8993 mutant mitochondrial DNA through generations and embryonic tissues in a family at risk of Leigh syndrome. J Pediatr (1997) 1.05
Longitudinal ocular motor study in corticobasal degeneration and progressive supranuclear palsy. Neurology (2000) 1.05
Dystonin is essential for maintaining neuronal cytoskeleton organization. Mol Cell Neurosci (1998) 1.04
Nuclear DNA origin of mitochondrial complex I deficiency in fatal infantile lactic acidosis evidenced by transnuclear complementation of cultured fibroblasts. J Clin Invest (1999) 1.04
The neuropsychological pattern of corticobasal degeneration: comparison with progressive supranuclear palsy and Alzheimer's disease. Neurology (1995) 1.03
Mapping of a second locus for familial hemiplegic migraine to 1q21-q23 and evidence of further heterogeneity. Ann Neurol (1997) 1.03
Hepatic and muscular presentations of carnitine palmitoyl transferase deficiency: two distinct entities. Pediatr Res (1988) 1.03
Antibody inhibition of the transcriptase activity of the rotavirus DLP: a structural view. J Mol Biol (2001) 1.03
Cerebellar processing of sensory inputs primes motor cortex plasticity. Cereb Cortex (2012) 1.02
Cerebellar rTMS stimulation may induce prolonged clinical benefits in essential tremor, and subjacent changes in functional connectivity: an open label trial. Brain Stimul (2012) 1.01
Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease. Mov Disord (2001) 1.01